期刊文献+

MRP3基因参与卵巢癌细胞拓扑替康耐药机制形成的研究

The study on the expression of MRP3 gene involved in Topotecan resistance in the human ovarian carcinoma cell line SKOV3/TPT.
下载PDF
导出
摘要 目的:分析人卵巢癌SKOV3/TPT多药耐药的分子机制,寻找可能参与拓扑替康(TPT)耐药机制的新基因。方法:采用大剂量间歇诱导法,对SKOV3细胞株用TPT反复冲击诱导培养,获得稳定的SKOV3/TPT;利用Affymetrix U133A基因表达谱芯片,比较SKOV3及SKOV3/TPT细胞的基因表达;从中选择高表达的MRP3基因进行RT-PCR验证。再将MRP3反义及正义寡核苷酸片段分别用脂质体转染进耐药细胞,用MTT法、流式细胞仪及半定量RT-PCR检测体外转染后细胞内TPT的荧光强度、耐药指数及MRP3 mRNA表达的改变。结果:基因芯片检测发现,有7个差异表达基因可能参与了SKOV3/TPT细胞的耐药,其中4个基因被上调,3个基因被下调,MRP3为上调最明显的基因。MRP3反义寡核苷酸转染SKOV3/TPT细胞后,可明显降低细胞内TPT的浓度及耐药指数(P<0.05),细胞内MRP3 mRNA的表达较未转染细胞下降了60.16%(P<0.05)。结论:SKOV3/TPT细胞耐药表型的形成涉及多个基因表达的改变。MRP3的高表达导致细胞内药物浓度降低,可能是卵巢癌细胞对TPT耐药的主要原因。 Objective:To study the molecular mechanism underlying multidrug resistanee and identify unknown genes that might be involved in drug resistance development in SKOV3/TPT cells. Methods:The TPT -resistant human ovarian carcinoma cell subline SKOV3/TPT was established with SKOV3 exposed to high-level concentration of TPT intervally and repeatedly. The differential expression of associated genes in SKOV3/TPT compared with SKOV3 were determined by Affymetrix U133A Gene Chips. PCR were performed to tested the transcription level of MRF3 gene which was over expressed in SKOV3/TPT . The antisense-phosphorothioate oligonucleotide (ASODN) including the translation initiation site of MRP3 mRNA and the sense oligonucleotide (SODN)were transferred into SKOV3/TPT cells by Lipofect-2000 (LF). The resistance index of topotecan, intracellular fluorescence intensity of TPT and MRP3 mRNA expression in SKOV3/TPT cells after transfected were detected respectively by methyl thiazolyl tetrazolium (MTT) assay, flow cytometry ( FCM ), and semiquantitative RT-PCR. Results:Gene chip revealed that there were seven differential expressed genes in SKOV3/TPT cells. MRP3, MRP7, SCN11A and EBP were up-regulated, MRP4, FIJ12443 and SEMA3C were down-regulated. RT-PCR were used to confirm the results. After transfer of MRP3-ASODN/LF into SKOV3/TPT cells,the resistance index to topotecan was decreased from 10.67 to 3. 165.The intracellular TPT fluorescence intensity was obviously increased from 4.55 ± 0. 75 to 9.05 ± 1.13 ( P 〈 0.05 ). The mRNA level of MRP3 was reduced to 60.16 % ( P 〈 0.05 ). Conclusions :There are some differentially expressed genes in SKOV3/TPT cells. The overexpression of MRP3 which mediated drug efflux may play an important role in the induction of TPT-resistance in ovarian cancer cell line.
出处 《现代妇产科进展》 CSCD 北大核心 2006年第11期822-825,共4页 Progress in Obstetrics and Gynecology
基金 首都医学发展科研基金(重点学科)资助课题(ZD199915)
关键词 卵巢肿瘤 基因芯片 拓扑替康 多药耐药蛋白3 Ovarian neoplasms cDNA chip Topotecan Multidrug resistance protein 3
  • 相关文献

参考文献2

二级参考文献13

  • 1王洁,刘叙仪,蒋薇.Co-transfection of MRP and bcl-2 antisense S-oligodeoxynucleotides reduces drug resistance in cisplatin-resistant lung cancer cells[J].Chinese Medical Journal,2000(10):93-96. 被引量:16
  • 2Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T,Gorlick R, Bertino J R. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidilate synthase. Biochim Biophys Acta, 2002, 1587(2-3): 164-173.
  • 3Suzuki T, Nishio K, Tanabe S. The MRP family and anticancer drug metabolism. Curr Drug Metab, 2001, 2(4): 367-377.
  • 4Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino J R. Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med, 1996, 335(14): 1041-1048.
  • 5Calatozzolo C, Gelati M, Ciusani E, Sciacca F L, Pollo B, Cajola L, Marras C, Silvani A, Vitellaro-Zuccarello L, Croci D, BoiardiA, Salmaggi A. Expression of drug resistance proteins Pgp,MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol, 2005, 74(2): 113-121.
  • 6Ruiz J C, Choi K H, von Hoff D D, Roninson I B, Wahl G M.Autonomously replicating episomes contain mdrl genes in a multidrug-resistant human cell line. Mol Cell Biol, 1989, 9(1):109-115.
  • 7Cole S P, Sparks K E, Fraser K, Loe D W, Grant C E, Wilson G M, Deeley R G.Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.Cancer Res, 1994,54(22): 5902-5910.
  • 8Ritter C A, Jedlitschky G, Meyer zu Schwabedissen H, Grube M,Kock K, Kroemer H K. Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev, 2005, 37(1):253-278.
  • 9Zeng H, Chen Z S, Belinsky M G, Rea P A, Kruh G D. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRPI: Effect of polyglutamylation on MTX transport. Cancer Res, 2001, 61 ( 19): 7225 -7232.
  • 10Hooijberg J H, Broxterman H J, Kool M, Assaraf Y G, Peters G J,Noordhuis P, Scheper R J, Borst P, Pinedo H M, Jansen G. Antifolate resistance mediated by the multidrug resistance protein MRP1 and MRP2. Cancer Res, 1999, 59(11): 2532-2535.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部